Biopharmaceuticals
News Release - October 13, 2006
Merck & Co., Inc. and Lundbeck Announce Update in Submission Plans for U.S. Approval of Gaboxadol
Source: Merck
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.